Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciences
Author:
- 1 March 2021
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 57 (3) , 106258
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Appearance of Macrolide-Resistant Bordetella pertussis Strains in ChinaAntimicrobial Agents and Chemotherapy, 2013
- Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest methodEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Emergence of Quinolone-Resistant Bordetella pertussis in JapanAntimicrobial Agents and Chemotherapy, 2009
- Efficacy of short-term treatment of pertussis with clarithromycin and azithromycinThe Journal of Pediatrics, 1996
- Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugsDiagnostic Microbiology and Infectious Disease, 1987
- Antimicrobial treatment of pertussisThe Journal of Pediatrics, 1969
- Susceptibility of Bordetella pertussis to ampicillinThe Journal of Pediatrics, 1966
- Antibiotic spectrum of Hemophilus pertussisThe Journal of Pediatrics, 1950
- The action of aureomycin, of Polymyxin B, and of streptomycin in experimental murine pertussisThe Journal of Pediatrics, 1949
- Treatment of pertussis with polymyxin B (aerosporin)The Journal of Pediatrics, 1949